carbostyril has been researched along with Infection, Toxoplasma gondii in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruzual, I; Dodean, RA; Doggett, JS; Krollenbrock, A; McConnell, EV; Nilsen, A; Pou, S; Riscoe, MK; Smilkstein, MJ; Winter, R; Zakharov, LN | 1 |
Bohne, W; Gross, U; Hegewald, J | 1 |
Alibana-Clouser, F; Antonyuk, SV; Brasseur, G; Capper, M; Donkin, D; Dovgin, S; Dubey, J; El Bissati, K; Esaa, F; Fishwick, C; Fraczek, L; Gordon, J; Hasnain, SS; He, Y; Hickman, M; Hood, L; Kent, M; Kim, E; Kim, TK; Lee, P; Lorenzi, H; Lukens, AK; Lykins, J; McLeod, R; McPhillie, M; Meunieur, B; Moulton, H; Muench, S; Roberts, CW; Sanders, J; Santos, T; Verma, SK; Wang, K; Weber, CR; Weiss, L; Wheeler, K; Wirth, D; Woods, S; Zhou, Y | 1 |
Alday, PH; Ben Mamoun, C; Bruzual, I; Doggett, JS; Nilsen, A; Pou, S; Riscoe, MK; Winter, R | 1 |
DARROW, EM; GINGRICH, WD | 1 |
5 other study(ies) available for carbostyril and Infection, Toxoplasma gondii
Article | Year |
---|---|
Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Drug Discovery; Drug Resistance; Electron Transport Complex III; Humans; Malaria, Falciparum; Mice; Molecular Structure; Phenyl Ethers; Plasmodium falciparum; Quinolones; Structure-Activity Relationship; Toxoplasma; Toxoplasmosis | 2018 |
Identification of dihydroorotate dehydrogenase as a relevant drug target for 1-hydroxyquinolones in Toxoplasma gondii.
Topics: Binding Sites; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Orotic Acid; Oxidoreductases Acting on CH-CH Group Donors; Point Mutation; Protozoan Proteins; Quinolones; Toxoplasma; Toxoplasmosis | 2013 |
New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections.
Topics: Animals; Cats; Cytochromes b; Disease Models, Animal; Drug Discovery; Drug Resistance; Feces; Humans; Oocysts; Parasite Egg Count; Plasmodium falciparum; Quinolones; Toxoplasma; Toxoplasmosis | 2016 |
Genetic Evidence for Cytochrome b Qi Site Inhibition by 4(1H)-Quinolone-3-Diarylethers and Antimycin in Toxoplasma gondii.
Topics: Antimycin A; Cytochromes b; Mitochondria; Quinolones; Toxoplasma; Toxoplasmosis | 2017 |
The effect of endochin on experimental toxoplasmosis.
Topics: Quinolones; Toxoplasmosis | 1951 |